Contact

For more information please contact:

Justin Leon
Director

M +61 (0) 417 438 544

A new direction in the treatment of Peyronie’s disease

Client: Janssen Australia When Janssen was granted a second indication for collagenase clostridium histolyticum by the Therapeutic Goods Administration – for the treatment of Peyronie’s disease – … MORE

Patient and physician demonstration kits

Client: Janssen Australia A common barrier to treatment with some drugs can be administration. This is certainly the case for Janssen’s treatment for advanced PAH, which is administered … MORE